MedPath

Intraoperative Angiography Using ICG in Rectal Cancer Patients to Prevent Anastamotic Leak After Laparoscopic Anterior Resection of the Rectum

Not Applicable
Recruiting
Conditions
Rectal Cancer
Interventions
Drug: Verdye Green
Registration Number
NCT05263336
Lead Sponsor
Jagiellonian University
Brief Summary

The study enrols patients with operative rectal cancer qualified for laparoscopic anterior resection. Patients are given first dose of indocyanine green iv intraoperatively (ICG) before choosing the appropriate site of the anastomosis, and the second dose after performing the anastomosis to confirm adequate blood supply to the anastomotis. The main outcome assessed is the frequency o anastomotic leak in comparison to the group of patients that do not undergo intraoperative ICG angiography.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
180
Inclusion Criteria
  • operative rectal cancer
Exclusion Criteria
  • known allergy toward indocyanic green

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
InterventionVerdye GreenIntraoperative verdye green iv administration to visualize blood supply to the anastomosis
Primary Outcome Measures
NameTimeMethod
Anastomotic leakUp to two weeks post surgery

Leakage in the anastomotic line defined as peritonitis requiring relaparotomy resulting from stool leakage from the anastomosis line

Secondary Outcome Measures
NameTimeMethod
Postsurgical IleusUp to 10 days post surgery

Prolonged postsurgical ileus defined as no oral diet toleration, nausea, vomiting, no gas or stool passage lasting more than 4 days post surgery

Trial Locations

Locations (1)

St John Grande Hospital

🇵🇱

Kraków, Lesser Poland, Poland

© Copyright 2025. All Rights Reserved by MedPath